Yutaka Takazawa

Yutaka Takazawa


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KIKentaro Inamura
Kentaro Inamura
YTYutaka Takazawa
Yutaka Takazawa
YIYosuke Inoue
Yosuke Inoue
YYYusuke Yokouchi
Yusuke Yokouchi
MKMaki Kobayashi
Maki Kobayashi
YIYuichi Ishikawa
Yuichi Ishikawa
B7-H3 (CD276), a member of the family of immune modulators, orchestrates antitumor immunity. To date, only small-sized studies have examined the association of B7-H3 expression with survival in pancreatic cancer, yielding inconclusive results. We evaluated tumor B7-H3 expression in 150 consecutive patients with pancreatic ductal adenocarcinoma using immunohistochemistry. B7-H3 expression was positive (≥10% tumor cells) in 99 of 150 (66%) cases of pancreatic cancer. We classified the tumors into four groups depending on B7-H3 expression (negative, low, intermediate, and high) and found that higher B7-H3 expression was independently associated with lower disease-free survival (DFS; for high vs. negative B7-H3 expression: multivariable hazard ratio (HR) = 3.12; 95% confidence interval (CI) = 1.48–6.15; Ptrend = 0.0026). Furthermore, the association of B7-H3 expression with survival differed according to the pathological stage (p-stage) (Pinteraction = 0.048, between p-stages I–II and III–IV). The association of B7-H3 positivity with lower DFS was stronger in tumors with p-stage I–II (multivariable HR = 3.10, 95% CI = 1.75–5.69; P < 0.0001) than in those with p-stage III–IV (multivariable HR = 1.20, 95% CI = 0.67–2.28; P = 0.55). We demonstrated that tumor high B7-H3 expression is independently associated with poor survival in patients with pancreatic cancer and that this association is stronger in tumors with p-stage I–II than in those with p-stage III–IV. B7-H3 expression may be a useful prognostic biomarker for identifying aggressive early-stage pancreatic cancer.

19 August 2020 in Cancers
Verified
Journal Article
Open access
PDF file
YTYasuyo Teramura
Yasuyo Teramura
MTMiwa Tanaka
Miwa Tanaka
YYYukari Yamazaki
Yukari Yamazaki
KYKyoko Yamashita
Kyoko Yamashita
YTYutaka Takazawa
Yutaka Takazawa
TNTakuro Nakamura
Takuro Nakamura
Fusion genes induced by chromosomal aberrations are common mutations causally associated with bone and soft tissue sarcomas (BSTS). These fusions are usually disease type-specific, and identification of the fusion genes greatly helps in making precise diagnoses and determining therapeutic directions. However, there are limitations in detecting unknown fusion genes or rare fusion variants when using standard fusion gene detection techniques, such as reverse transcription-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH). In the present study, we have identified 19 novel fusion genes using target RNA sequencing (RNA-seq) in 55 cases of round or spindle cell sarcomas in which no fusion genes were detected by RT-PCR. Subsequent analysis using Sanger sequencing confirmed that seven out of 19 novel fusion genes would produce functional fusion proteins. Seven fusion genes detected in this study affect signal transduction and are ideal targets of small molecule inhibitors. YWHAE-NTRK3 expression in mouse embryonic mesenchymal cells (eMCs) induced spindle cell sarcoma, and the tumor was sensitive to the TRK inhibitor LOXO-101 both in vitro and in vivo. The combination of target RNA-seq and generation of an ex vivo mouse model expressing novel fusions provides important information both for sarcoma biology and the appropriate diagnosis of BSTS.

12 June 2023 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
YSYasuyuki Shigematsu
Yasuyuki Shigematsu
GAGulanbar Amori
Gulanbar Amori
KTKazuhito Tanaka
Kazuhito Tanaka
KKKeiichiro Kitahama
Keiichiro Kitahama
HKHiroaki Kanda
Hiroaki Kanda
KIKentaro Inamura
Kentaro Inamura

19 August 2020 in Acta Cytologica
Verified
Journal Article
Closed access
PDF file
SIShuhei Ishii
Shuhei Ishii
TITakahiko Ito
Takahiko Ito
MYMarisa Yamada
Marisa Yamada
NYNaoko Yamazaki
Naoko Yamazaki
KIKoichi Ikebata
Koichi Ikebata
YTYutaka Takazawa
Yutaka Takazawa
Objective: To investigate the cytological findings of lobular endocervical glandular hyperplasia (LEGH) associated with adenocarcinoma and to clarify its characteristics and the coexisting adenocarcinoma using histochemistry and immunohistochemistry. Methods: Eighteen surgical cases of LEGH of the uterine cervix were retrospectively reviewed and classified into 3 groups: pure (pure type), atypical (atypical type), and LEGH with adenocarcinoma (mixed type). The mixed type is defined as LEGH or atypical LEGH with in situ or invasive adenocarcinoma. Cytological findings of conventional endocervical smear specimens (Papanicolaou stain) were analyzed. Histochemistry (periodic acid-Schiff reaction) and immunohistochemistry (M-GGMC-1, Muc-6 glycoprotein, and Ki-67) were performed using tissue specimens. Results: Cytologically, the pure type (7 cases) is characterized by glandular cell clusters that tended to form monolayered sheets with uniformly small nuclei and contain golden-yellowish mucin, whereas atypical (5 cases) and mixed (6 cases) types are characterized by glandular cell clusters similar to those of the pure type, but with complex glandular structures and mucin localization on the surface of glandular cell clusters. Ki-67 labeling index was significantly higher in atypical and mixed types than that in the pure type. Gastric-type mucinous carcinoma (MC-G) was observed in 2 out of 6 cases with mixed type. Conclusions: LEGH is found to be associated with adenocarcinoma types other than MC-G. Complex glandular structures or mucin localization on the surface of glandular cell clusters may be useful cytological findings to detect atypical and mixed types of LEGH.

1 February 2020 in Clinical Imaging
Verified
Journal Article
Closed access
KNKatsuhiko Naito
Katsuhiko Naito
YSYasuyuki Shigematsu
Yasuyuki Shigematsu
YFYoshimasa Fujiwara
Yoshimasa Fujiwara
KIKentaro Inamura
Kentaro Inamura
YTYasuyuki Togashi
Yasuyuki Togashi
KMKiyoshi Matsueda
Kiyoshi Matsueda